Ceapro Inc. (TSX VENTURE:CZO) today announced the granting of stock options to
its employees, directors, and officers for a total of 1,400,000 stock options,
each with an exercise price of $0.10. Each grant vests in three equal
instalments, the first of which vests immediately with the second and third
instalments vesting on the first and second anniversaries of the date of grant.
Each option is exercisable, once vested, for a period of ten years from the date
of grant.


Of note, a total of 575,000 of the stock options were granted to directors and
officers. The granting of all options is subject to TSX Venture approval.


About Ceapro Inc.

Ceapro Inc. is a Canadian growth-stage biotechnology company. Primary business
activities relate to the development and commercialization of natural products
for personal care and cosmetic industries using proprietary technology and
natural, renewable resources. The commercial line of natural active ingredients
include beta glucan, avenanthamides (colloidal oat extract), oat powder, oat
oil, oat peptides, and lupin peptides.


To learn more about Ceapro, visit www.ceapro.com. 

FOR FURTHER INFORMATION PLEASE CONTACT: 
Ceapro Inc.
Branko Jankovic
Chief Financial Officer
(780) 917-8376 (Edmonton)
bjankovic@ceapro.com
www.ceapro.com
Ceapro (TSXV:CZO)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024 Ceapro 차트를 더 보려면 여기를 클릭.
Ceapro (TSXV:CZO)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024 Ceapro 차트를 더 보려면 여기를 클릭.